Copyright
©The Author(s) 2018.
World J Gastrointest Endosc. Apr 16, 2018; 10(4): 74-82
Published online Apr 16, 2018. doi: 10.4253/wjge.v10.i4.74
Published online Apr 16, 2018. doi: 10.4253/wjge.v10.i4.74
Table 5 Type of treatment between ≤ 48 h, 48 h-14 d and ≥ 14 d groups n (%)
| Type of treatment | All (n = 115) | ≤ 48 h (n = 39) | 48 h-14 d (n = 35) | ≥ 14 d (n = 41) | P value1 |
| Conservative | 62 (53.9) | 13 (33.3) | 21 (60) | 28 (68.3) | 0.005 |
| Endoscopic | 30 (26.1) | 14 (35.9) | 6 (17.1) | 10 (24.4) | 0.18 |
| Surgical | 19 (16.5) | 9 (23.1) | 7 (20) | 3 (7.3) | 0.13 |
| Radiological | 3 (2.6) | 2 (5.1) | 1 (2.9) | 0 | 0.353 |
| Endoscopic + Surgical | 1 (0.9) | 1 (2.6) | 0 | 0 | 0.37 |
- Citation: Gomes C, Pinho R, Rodrigues A, Ponte A, Silva J, Rodrigues JP, Sousa M, Silva JC, Carvalho J. Impact of the timing of capsule endoscopy in overt obscure gastrointestinal bleeding on yield and rebleeding rate - is sooner than 14 d advisable? World J Gastrointest Endosc 2018; 10(4): 74-82
- URL: https://www.wjgnet.com/1948-5190/full/v10/i4/74.htm
- DOI: https://dx.doi.org/10.4253/wjge.v10.i4.74